Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
0 investors
Spectral Platforms develops imaging and sensing technologies based on optical and materials science innovations. The company was founded by Ravi Verma, a materials scientist with expertise in optics and MEMS, and is supported by a board of distinguished scientists and industry leaders.
0 investors
0 investors
0 investors
0 investors
0 investors
Sperity Health provides early detection and preventive health screening programs for individuals and employers, coordinating advanced diagnostics, wearable monitoring, and personalized care across sleep, nutrition, exercise, and preventive screening to shift healthcare from reactive to proactive.
0 investors
0 investors
BlueRiver Acquisition Corp. is a special purpose acquisition company (SPAC) domiciled in the Cayman Islands and listed on the NYSE under "BLUA.U", seeking acquisition targets primarily in the technology, media, telecom, and entertainment industries across North America, Europe, and Asia.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Spinnaker Biosciences develops porous silicon, porous silicon oxide, and silicon/polymer composite materials engineered as controlled-release drug delivery vehicles. Its biocompatible, biodegradable particles provide protected storage and sustained release of therapeutic payloads, with surface chemistry that supports targeting agents such as peptides and antibodies.
0 investors
Spinogenix is a biopharmaceutical company developing therapies to restore synaptic function, with a pipeline aimed at neurological and neurodegenerative conditions.
0 investors
0 investors
Spiral Dot, based in Silicon Valley, works on improving the consistency of cancer care delivery. Its focus is on reducing variation in treatment quality across different patient circumstances and geographic locations.
0 investors
Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform. Its lead program, SPT-2101, is a sustained-release dexamethasone formulation for treating Ménière's disease.
0 investors
0 investors
0 investors
0 investors
Splash is a platform that identifies, acquires, and scales consumer wellness brands powered by cannabinoids and adjacent plant-based ingredients. The company targets the emerging cannabinoid wellness market with a focus on product quality, regulatory compliance, and brand accessibility.
0 investors